| |
| |
|
| Insider
Information: |
Steiner Mitchell Shuster |
| Relationship: |
President and CEO, Dir... |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
9,072,631 |
|
|
Indirect Shares
|
2,687,445 |
|
|
| Direct
Value |
$7,104,507 |
|
|
|
Indirect Value
|
$1,003,605 |
|
|
| Total
Shares |
11,760,076 |
|
|
| Total
Value |
$8,108,112 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-8.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -250.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
Chief Executive Office... |
2012-07-16 |
2,129,922 |
2012-07-16 |
2,543,445 |
Premium* |
|
|
Veru Inc |
VERU |
President and CEO, Dir... |
2024-05-24 |
6,942,709 |
2024-05-24 |
144,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Chief Executive OfficerOfficer |
• • • |
2004-02-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,662,147 |
|
- |
|
| VERU |
Veru Inc |
President and CEOOfficer |
• • • |
2016-10-31 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
645,502 |
|
- |
|
| VERU |
Veru Inc |
President and CEOOfficer |
• • • |
2016-10-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
633,589 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-10 |
4 |
AS |
$11.11 |
$3,335 |
I/I |
(300) |
492,700 |
|
- |
|
| VERU |
Veru Inc |
President and CEO |
• • • |
2019-02-07 |
4 |
AS |
$1.50 |
$450 |
D/D |
(300) |
7,731,267 |
0 |
- |
|
| VERU |
Veru Inc |
President and CEO |
• • – |
2024-05-23 |
4 |
S |
$1.35 |
$405 |
D/D |
(300) |
7,006,088 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-26 |
4 |
AS |
$11.07 |
$3,609 |
I/I |
(326) |
468,980 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-27 |
4 |
AS |
$9.91 |
$4,955 |
I/I |
(500) |
390,766 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-23 |
4 |
AS |
$10.88 |
$8,547 |
I/I |
(779) |
465,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-06 |
4 |
AS |
$11.46 |
$9,389 |
I/I |
(811) |
437,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-26 |
4 |
AS |
$10.10 |
$9,187 |
I/I |
(907) |
395,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-19 |
4 |
AS |
$10.55 |
$10,212 |
I/I |
(968) |
408,032 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2012-04-12 |
4 |
S |
$3.50 |
$3,980 |
I/I |
(1,137) |
1,992,986 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-24 |
4 |
AS |
$10.56 |
$12,126 |
I/I |
(1,138) |
458,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-10 |
4 |
AS |
$11.18 |
$12,932 |
I/I |
(1,150) |
486,000 |
|
- |
|
| VERU |
Veru Inc |
President and CEO |
• • • |
2019-10-09 |
4 |
AS |
$2.11 |
$2,824 |
D/D |
(1,339) |
7,502,760 |
0 |
- |
|
| VERU |
Veru Inc |
President and CEO |
• • • |
2019-02-28 |
4 |
AS |
$1.50 |
$2,250 |
D/D |
(1,500) |
7,718,162 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2009-01-27 |
4 |
B |
$10.54 |
$17,918 |
I/I |
1,700 |
1,700 |
2.56 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2009-01-28 |
4 |
B |
$10.53 |
$17,901 |
I/I |
1,700 |
3,400 |
2.56 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2009-01-29 |
4 |
B |
$10.64 |
$18,088 |
I/I |
1,700 |
5,100 |
2.56 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-16 |
4 |
AS |
$11.39 |
$20,611 |
I/I |
(1,776) |
477,443 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-17 |
4 |
AS |
$11.61 |
$24,436 |
I/I |
(2,082) |
476,643 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2009-11-10 |
4 |
B |
$3.73 |
$8,579 |
I/I |
2,300 |
133,741 |
2.56 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-30 |
4 |
AS |
$10.55 |
$25,604 |
I/I |
(2,414) |
444,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-07 |
4 |
AS |
$10.85 |
$27,666 |
I/I |
(2,496) |
430,000 |
|
- |
|
148 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
